Treatment of Sarcoidosis in Neurosarcoidosis — Severe Disabling Disease, Acutely and Severely Ill

Clinical Scenario

This protocol applies to patients with sarcoidosis involving the nervous system (neurosarcoidosis) who present with severe, disabling neurological disease and are acutely and severely ill. The combination of active neurosarcoidosis and an acute, severe presentation calls for prompt, structured management.

Treatment Approach

For patients who are acutely and severely ill, intravenous corticosteroid therapy is a primary treatment option. Further options, their sequencing, and patient-specific selection criteria are detailed in the full protocol.

Treatment goal: Clinical response within 2–3 months.

Instant Access to Structured Evidence-Based Regimens

References

For patients who are acutely and severely ill, intravenous methylprednisolone for three days or anti-TNF therapy is recommended.

Infliximab can also be used for chronic treatment or to “bridge” a patient until an immunosuppressive drug’s benefit becomes evident, typically in 2–3 months.

View source ↗